Liposome-based nerve block to improve recovery after VATS lung surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In patients undergoing video-assisted thoracoscopic partial pneumonectomy, the investigators compare a liposomal bupivacaine intercostal nerve block to a conventional bupivacaine block. The goal is to see if the long-acting formula improves overall recovery, reduces pain, and lowers opioid use, measured by the QoR-15 score at 24 hours post-surgery. The trial is phase 4 and interventional, with adults aged 18-65 and ASA I-II undergoing thoracic surgery. Outcomes focus on postoperative recovery quality, analgesia, and safety of the nerve block regimen.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients scheduled for thoracic surgery under general anesthesia via thoracoscopic approach;
* Age 18-65 years;
* Classified as Grade I-II by the American Society of Anesthesiologists (ASA).

Exclusion Criteria:

* History of local anesthetic allergy.
* Chronic opioid users.
* Contraindications for nerve block, including infection at the puncture site and coagulation disorders;
* Language communication impairment.
* Other conditions unsuitable for inclusion in the trial.

Where it's running

• SanMing First Hospital
  Sanming, Fujian, China Recruiting

Study contacts

• Principal investigator: Huifen Lin, MD — No. 15, Liedong Street, Sanyuan District, Sanming City, Fujian Province
• Study coordinator: Huifen Lin, MD
• Email: smyhb0598@163.com
• Phone: （0598）8803263

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Liposomal Bupivacaine Plus Plain Bupivacaine vs Dexamethasone Plus Plain Bupivacaine for High-Risk Pain After Supraclavicular Brachial Plexus Block

  This trial tests whether liposomal bupivacaine with plain bupivacaine can better control postoperative pain after distal radial fracture surgery in patients at high risk of severe pain, compared with dexamethasone plus plain bupivacaine.

  Recruiting Phase 3 The University of Hong Kong · Hong Kong · NCT07665762

• Liposomal Bupivacaine vs Ropivacaine for TAP Block in Laparoscopic Gallbladder Surgery

  In people having gallbladder removal with laparoscopy, this study tests whether liposomal bupivacaine for a TAP block reduces pain compared with standard ropivacaine.

  Recruiting Tianjin First Central Hospital · Tianjin, Tianjin Municipality · NCT07577934

• Liposomal bupivacaine TAP block to reduce pain after laparoscopic gynecologic cancer surgery

  This trial will test whether a long‑acting liposomal form of bupivacaine given as a transversus abdominis plane (TAP) block reduces postoperative pain for adults having laparoscopic gynecologic oncology surgery.

  Recruiting Beijing Tiantan Hospital · Beijing, Beijing Municipality · NCT07458295

• Liposomal bupivacaine via transversus abdominis plane block to reduce pain after laparoscopic surgery

  This trial will test whether adding liposomal bupivacaine to an ultrasound-guided TAP block reduces postoperative pain and opioid use in adults having elective laparoscopic abdominal surgery.

  Recruiting Beijing Tiantan Hospital · Beijing, Beijing Municipality · NCT07458282

• Liposomal bupivacaine for pain after laparoscopic surgery

  This trial will test whether a long-acting, liposomal form of bupivacaine given at the incision reduces postoperative pain and the need for oral pain medicines in adults having elective laparoscopic procedures.

  Recruiting Beijing Tiantan Hospital · Beijing, Beijing Municipality · NCT07458256

• Liposomal bupivacaine for rhomboid intercostal nerve block to reduce pain after VATS

  We will test whether adding long‑acting liposomal bupivacaine to a rhomboid intercostal nerve block reduces pain after video‑assisted thoracoscopic lung surgery in adults.

  Recruiting Beijing Tiantan Hospital · Beijing, Beijing Municipality · NCT07441902

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.